Speaker: Mark Dysinger

Mark Dysinger, Senior Scientist, Pharmacokinetics, Dynamics, and Metabolism, Pfizer Global Research and Development, presented Glucagon-Like Peptide 1 (GLP-1) Quantitation: Gyrolab vs Other Detection Platforms at the 2nd Annual North American Gyrolab Seminar.

The Gyrolab assay reduced turnaround time considerably compared to assays based on ELISA and MSD technology with:

  • 3 × faster assay development
  • 3 × shorter assay run time